Intelligence Platform

Patents

Browse 2,828 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 6376467

Use of inhibitors of protein kinase C epsilon to treat pain

The Regents of the University of California · Granted Tue Apr 23 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6376515

Benzamides and related inhibitors of factor Xa

COR Therapeutics, Inc. · Granted Tue Apr 23 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6372778

Sulfonamide inhibitors of aspartyl protease

Vertex Pharmaceuticals Incorporated · Granted Tue Apr 16 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6369063

Selective factor Xa inhibitors

COR Therapeutics, Inc. · Granted Tue Apr 09 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6369080

Selective factor Xa inhibitors

COR Therapeutics, Inc. · Granted Tue Apr 09 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6365359

Inhibitors of prion formation

The Regents of the University of California · Granted Tue Apr 02 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6355610

Inhibitors of formation of protease resistant prion protein

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 12 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6355619

Peptide tumor cell growth inhibitors

The Board of Regents of the University of Texas System · Granted Tue Mar 12 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6353097

Nucleic acids encoding signal transduction inhibitors of allergic reactions

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 05 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6350741

Inhibitors of interleukin-1&bgr; converting enzyme

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 26 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6350785

Methods and compositions for topical treatment of damaged tissue using reactive oxygen met

Maxim Pharmaceuticals, Inc. · Granted Tue Feb 26 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6344465

Inhibitors of IMPDH enzyme

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 05 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6333033

Autoantibody inhibitors

The Regents of the University of California · Granted Tue Dec 25 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6333321

Selective factor Xa inhibitors

COR Therapeutics, Inc. · Granted Tue Dec 25 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6329365

Inhibitors of interleukin-1.beta. converting enzyme

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 11 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6323226

Treatment of heart disease with cox-2 inhibitors

The Board of Regents of the University of Texas System · Granted Tue Nov 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6319946

Inhibitors of aspartyl protease

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6310088

Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity

Darwin Discovery Limited · Granted Tue Oct 30 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6310107

Amine compounds, their production and use as amyloid-.beta. production inhibitors

Takeda Chemical Industries Ltd. · Granted Tue Oct 30 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6291469

Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation

COR Therapeutics, Inc. · Granted Tue Sep 18 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6291664

Method of eliminating inhibitory/instability regions of mRNA

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 18 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6281196

Isolation and structural elucidation of the human cancer cell growth inhibitory compound d

THE ARIZONA BOARD OF REGENTS · Granted Tue Aug 28 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6277827

Single morphic forms of metalloproteinase inhibitors

Darwin Discovery Limited · Granted Tue Aug 21 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6270781

Method and compositions for topical treatment of damaged tissue using reactive oxygen meta

Maxim Pharmaceuticals, Inc. · Granted Tue Aug 07 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired